The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: A Health Care Resource and Infrastructure Assessment

Navneet S. Majhail, Elizabeth A. Murphy, Ellen M. Denzen, Stacy S. Ferguson, Claudio Anasetti, Arthur Bracey, Linda Burns, Richard Champlin, Norman Hubbard, Miriam Markowitz, Richard T. Maziarz, Erin Medoff, Joyce Neumann, Kim Schmit-Pokorny, Daniel J. Weisdorf, Deborah S. Yolin Raley, Jeffrey Chell, Edward L. Snyder

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

Hematopoietic cell transplantation (HCT) is the only known curative therapy for many patients with life-threatening hematologic and oncologic diseases. It is estimated that the National Marrow Donor Program® (NMDP) will facilitate 10,000 transplants by 2015, double the current number. To better understand the existing personnel and center infrastructure for HCT in the country and to address system capacity challenges to the future growth of HCT, the NMDP convened a diverse group of stakeholders and thought leaders representing HCT physicians, physician assistants, nurse practitioners, nurses, pharmacists, other healthcare providers, HCT program directors, hospital administrators, payors, and professional organizations. Working groups were formed to identify: capacity issues because of shortages in human resources, structural constraints, and patient access barriers including diversity and healthcare disparity challenges; recommendations to address challenges; and stakeholders to engage. This report details the deliberations and recommendations of a national symposium, " Hematopoietic Cell Transplantation in 2020: A Health Care Resource and Infrastructure Assessment," held in September 2010.

Original languageEnglish (US)
Pages (from-to)172-182
Number of pages11
JournalBiology of Blood and Marrow Transplantation
Volume18
Issue number2
DOIs
StatePublished - Feb 1 2012

    Fingerprint

Keywords

  • Hematopoietic cell transplantation
  • National Marrow Donor Program
  • System capacity
  • Workforce shortage

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Majhail, N. S., Murphy, E. A., Denzen, E. M., Ferguson, S. S., Anasetti, C., Bracey, A., Burns, L., Champlin, R., Hubbard, N., Markowitz, M., Maziarz, R. T., Medoff, E., Neumann, J., Schmit-Pokorny, K., Weisdorf, D. J., Yolin Raley, D. S., Chell, J., & Snyder, E. L. (2012). The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: A Health Care Resource and Infrastructure Assessment. Biology of Blood and Marrow Transplantation, 18(2), 172-182. https://doi.org/10.1016/j.bbmt.2011.10.004